Logo for Immunovia

Immunovia Investor Relations Material

Latest events

Logo for Immunovia

Q1 2024

Immunovia
Logo for Immunovia

Q1 2024

29 Apr, 2024
Logo for Immunovia

Q4 2023

21 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Immunovia

Access all reports
Segment Data
Access more data
Net sales by
Products and services
Royalty
Tests
Expenses by
Financials
Immunovia AB, a Swedish diagnostic company, develops and commercializes blood tests in Sweden and internationally. The company was founded in 2007 and is listed on Nasdaq Stockholm First North Premier under the ticker IMMUV. Immunovia focuses on blood markers with an impact on health risk assessment, prevention and drug development. The tests have the potential to significantly improve doctors' possibilities to predict and prevent people from getting ill. The most advanced applications for our tests are for important risk groups such as breast cancer patients, heart attack cases, or diabetes type 2 sufferers. Immunovia AB is headquartered in Lund, Sweden.